Answer:
Drug-drug interactions (DDIs) are one of the commonest causes of medication error in developed countries, particularly in the elderly due to poly-therapy, with a prevalence of 20-40%. In particular, poly-therapy increases the complexity of therapeutic management and thereby the risk of clinically important DDIs, which can both induce the development of adverse drug reactions or reduce the clinical efficacy. DDIs can be classify into two main groups: pharmacokinetic and pharmacodynamic. In this review, using Medline, PubMed, Embase, Cochrane library and Reference lists we searched articles published until June 30 2012, and we described the mechanism of pharmacokinetic DDIs focusing the interest on their clinical implications.
Keywords: Absorption, adverse drug reaction, distribution, drug-drug interactions, excretion, metabolism, poly-therapy
Inject air into the vial with the eye of the needle immersed in the fluid.
A small needle is used to inject a substance into the tissue layer separating the skin and the muscle during a subcutaneous injection to deliver medication.
The steps involved in giving a subcutaneous injection are:
- washing hands in warm water and soap.
- assembling the necessary tools, including alcohol pads, gauze, needles, and syringes.
- examination and cleaning of the injection site.
- Putting the drug in the syringe entails:
- the vial's cap is taken off.
- air being injected into the syringe.
- inflating the virus with air.
- medicine discontinuation
- eliminating air bubbles.
- distributing the medicine.
Here is another question with an answer similar to this about subcutaneous injection: brainly.com/question/4278546
#SPJ4
The answer would be Dura Mater
Hope this helps!
Answer:
The white blood cells i.e. granulocytes and macrophages are specifically stimulated by GM-CSF in response to chemotherapy in cancer patients.
Explanation:
The colony stimulating factors (CSFs) are the regulators of granulocytes and macrophages in blood. The CSFs has the potential to regenerate the white blood cells damaged during chemotherapy. Thus, CSFs mobilize the stem cells to enhance the immune process and produce hematopoietic cells such as granulocytes, macrophages in cancer patients. The CSFs resemble hormones that are specifically targeted to produce blood cells in specified regions where the quantity of those cells is low. The CSFs belong to a group of regulatory factors also known as cytokines and does not produce only a single cell type but stimulates colonies of different blood cell types for any specific organ. Hematopoietic cells produced by CSF are step-wise and formation of blast colonies take place initially. Afterwards, the blast cells regenerate and differentiated into multiple progenitor cells consisting of granulocytes, monocytes, macrophages, eosinophills, erythroids, and lymphocytes. The progenitor cells in the granulocyte-macrophage lineage matures into neutrophilic granulocytes and macrophages.
Out of all types of CSF colonies, the Granulocyte-Macrophage (GM-CSF) colony is specially involved in regenerating immune responses in cancer patients. These cytokines stimulates the dendritic cell formation and produces dendritic activity against the cancerous cells. These GM-CSF colonies enhance the immune response of host against melanomas, tumors by reducing their growth and inducing remission. Hence, it can be said that granulocytes and macrophages are infection protective cells and elevates dangerously low levels of white blood cells in cancer patients following chemotherapy. The GM-CSF induction regenerates the bone marrow which is damaged and improves stem cells production.